Latest News and Press Releases

EDINBURGH, Scotland and VILLIGEN, Switzerland, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Cumulus Oncology, Europe’s first oncology-focused biotech creation company, announces that, in partnership with its...

EDINBURGH, Scotland, June 10, 2024 (GLOBE NEWSWIRE) -- Cumulus Oncology, Europe’s first oncology-focused biotech company creation factory, announces the appointment of Catherine Lewis La Torre to...

Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation Newly appointed CEO, Dr Xavier Leroy, will...

Cumulus Oncology raises £9m in seed financing Eos Advisory-led round includes new corporate investor the Scottish National Investment Bank Proceeds from the financing will be used to support Cumulus...

Cumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets Resulting IP will be licensed into a newly created Cumulus company ...

  LDC and Cumulus Oncology announce collaboration Dortmund, Germany, and Edinburgh, Scotland, March 22nd, 2021. The Lead Discovery Center GmbH (LDC) and Cumulus Oncology announce the signing of a...

Modulus Oncology Appoints Tim Edwards as Chairman Sheffield, UK, 11 January 2021:  Modulus Oncology, a new and rapidly emerging private biotech company focused on treating hard-to-treat cancers,...

Modulus Oncology Appoints Tim Edwards as Chairman Sheffield, UK, 11 January 2021:  Modulus Oncology, a new and rapidly emerging private biotech company focused on treating hard-to-treat cancers,...

University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers First-in-class drug blocks key signals required for tumour growth and metastasisHighly...